Oudemans-van Straaten Heleen M, van der Voort Peter J, Hoek Frans J, Bosman Rob J, van der Spoel Johan I, Zandstra Durk F
Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, P.O. Box 95500, 1090 HM Amsterdam, The Netherlands.
Intensive Care Med. 2002 Feb;28(2):130-8. doi: 10.1007/s00134-001-1140-2. Epub 2001 Nov 23.
To assess whether gastrointestinal permeability (GIP) at intensive care unit (ICU) admission, measured by differential sugar absorption, is related to severity of disease and multiple organ failure (MOF). Post hoc, to analyse the relation between the urinary sugar recovery and renal function.
Prospective observational cohort study.
Eighteen-bed general ICU of a teaching hospital.
Sixty-four ventilated patients admitted with MOF.
GIP was assessed within 24 h using cellobiose (C), sucrose (S) and mannitol (M) absorption.
Severity of disease: APACHE II and III, SAPS II and MPM II systems. Organ failure: SOFA, MODS and Goris score. The median urinary recovery of C was 0.147% (range 0.004-2.145%), of S 0.249% (0.001-3.656%) and of M 10.7% (0.6-270%). In 16 patients, M recovery was over 100% of the oral dose. They received red blood cell transfusion (RBC). In the non-transfused, the median cellobiose/mannitol (CM) ratio was 0.015 (0.0004-0.550). CM ratio was not related to severity of disease and inversely related to the SOFA score ( r=-0.30, p=0.04). Post hoc regression analysis showed that recoveries of C, S and M were positively related to urinary volume. Recoveries of C and S, but not of M, were positively related to creatinine clearance. The CM ratio corrected for diuresis, but was inversely related to creatinine clearance.
Differential C, S and M absorption testing is unreliable after RBC transfusion, since bank blood contains mannitol. The excretion of C and S, but not of M, is limited by renal dysfunction. Differential sugar absorption is not reliable to test GIP in MOF patients, since non-permeability related factors act as confounders.
通过不同糖类吸收情况来评估重症监护病房(ICU)入院时的胃肠道通透性(GIP)是否与疾病严重程度及多器官功能衰竭(MOF)相关。事后分析尿糖回收率与肾功能之间的关系。
前瞻性观察性队列研究。
一家教学医院的拥有18张床位的综合ICU。
64例因MOF入院的机械通气患者。
在24小时内通过纤维二糖(C)、蔗糖(S)和甘露醇(M)吸收情况评估GIP。
疾病严重程度:急性生理与慢性健康状况评分系统(APACHE)II和III、简化急性生理学评分系统(SAPS)II和死亡率预测模型(MPM)II。器官功能衰竭:序贯器官衰竭评估(SOFA)、多器官功能障碍综合征(MODS)和戈里斯评分。C的尿回收率中位数为0.147%(范围0.004 - 2.145%),S为0.249%(0.001 - 3.656%),M为10.7%(0.6 - 270%)。16例患者中,M回收率超过口服剂量的100%。他们接受了红细胞输血(RBC)。未输血患者中,纤维二糖/甘露醇(CM)比值中位数为0.015(0.0004 - 0.550)。CM比值与疾病严重程度无关,与SOFA评分呈负相关(r = -0.30,p = 0.04)。事后回归分析显示,C、S和M的回收率与尿量呈正相关。C和S的回收率与肌酐清除率呈正相关,但M的回收率与肌酐清除率无关。校正利尿后的CM比值与肌酐清除率呈负相关。
红细胞输血后,纤维二糖、蔗糖和甘露醇吸收差异检测不可靠,因为库存血中含有甘露醇。C和S的排泄受肾功能限制,但M不受此影响。在MOF患者中,不同糖类吸收检测GIP不可靠,因为非通透性相关因素起混杂作用。